Temsirolimus suppresses colony formation of head and neck squamous cell carcinoma epithelial cells

Authors :: Lück, B
Reiche, A
Boehm, A
Dietz, A
Herrmann, K
Wichmann, G
Source :: 82. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf-und Hals-Chirurgie; 20110601-20110605; Freiburg i. Br.; DOC11hnod211 /20110419/
Publication Year :: 2011
Publisher :: German Medical Science GMS Publishing House, 2011.
Abstract: Introduction: The mTOR inhibitor temsirolimus (TEM) is introduced into palliative therapy of advanced head and neck squamous cell carcinoma (HNSCC) after failure of platinum-based chemo- or radiochemotherapy. Purpose: To analyze the effect of TEM and whether TEM combined with cisplatin (Cis) exerts[for full text, please go to the a.m. URL]<br />82. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie

Language :: English
Database :: OpenAIRE
Journal :: 82. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf-und Hals-Chirurgie; 20110601-20110605; Freiburg i. Br.; DOC11hnod211 /20110419/
Accession number :: edsair.doi.dedup.....446a6a1c90c8452367416744bc8a82ce
Full Text :: https://doi.org/10.3205/11hnod211

Full Text Access

Tools